Propanc Biopharma Stock Market Value
| PPCB Stock | USD 0.0003 0.0001 50.00% |
| Symbol | Propanc |
Propanc Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Propanc Biopharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Propanc Biopharma.
| 11/27/2024 |
| 12/27/2024 |
If you would invest 0.00 in Propanc Biopharma on November 27, 2024 and sell it all today you would earn a total of 0.00 from holding Propanc Biopharma or generate 0.0% return on investment in Propanc Biopharma over 30 days. Propanc Biopharma is related to or competes with Mesabi Trust, Nutanix, Morningstar Unconstrained, Thrivent High, Via Renewables, T Rowe, and 70082LAB3. Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, ... More
Propanc Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Propanc Biopharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Propanc Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 30.17 | |||
| Information Ratio | 0.088 | |||
| Maximum Drawdown | 83.33 | |||
| Value At Risk | (33.33) | |||
| Potential Upside | 50.0 |
Propanc Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Propanc Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Propanc Biopharma's standard deviation. In reality, there are many statistical measures that can use Propanc Biopharma historical prices to predict the future Propanc Biopharma's volatility.| Risk Adjusted Performance | 0.0817 | |||
| Jensen Alpha | 1.62 | |||
| Total Risk Alpha | 0.6963 | |||
| Sortino Ratio | 0.0568 | |||
| Treynor Ratio | 0.543 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Propanc Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Propanc Biopharma Backtested Returns
Propanc Biopharma is out of control given 3 months investment horizon. Propanc Biopharma maintains Sharpe Ratio (i.e., Efficiency) of 0.0936, which implies the firm had a 0.0936% return per unit of risk over the last 3 months. We were able to break down twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.88% are justified by taking the suggested risk. Use Propanc Biopharma Risk Adjusted Performance of 0.0817, semi deviation of 12.13, and Coefficient Of Variation of 1101.77 to evaluate company specific risk that cannot be diversified away. Propanc Biopharma holds a performance score of 7 on a scale of zero to a hundred. The company holds a Beta of 3.24, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Propanc Biopharma will likely underperform. Use Propanc Biopharma expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to analyze future returns on Propanc Biopharma.
Auto-correlation | 0.22 |
Weak predictability
Propanc Biopharma has weak predictability. Overlapping area represents the amount of predictability between Propanc Biopharma time series from 27th of November 2024 to 12th of December 2024 and 12th of December 2024 to 27th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Propanc Biopharma price movement. The serial correlation of 0.22 indicates that over 22.0% of current Propanc Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.22 | |
| Spearman Rank Test | 0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Propanc Biopharma lagged returns against current returns
Autocorrelation, which is Propanc Biopharma pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Propanc Biopharma's pink sheet expected returns. We can calculate the autocorrelation of Propanc Biopharma returns to help us make a trade decision. For example, suppose you find that Propanc Biopharma has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Propanc Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Propanc Biopharma pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Propanc Biopharma pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Propanc Biopharma pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Propanc Biopharma Lagged Returns
When evaluating Propanc Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Propanc Biopharma pink sheet have on its future price. Propanc Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Propanc Biopharma autocorrelation shows the relationship between Propanc Biopharma pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Propanc Biopharma.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Propanc Pink Sheet
Propanc Biopharma financial ratios help investors to determine whether Propanc Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Propanc with respect to the benefits of owning Propanc Biopharma security.